ACI Clinical Announces Platform for Data Safety Monitoring Committees - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
ACI Clinical Announces Platform for Data Safety Monitoring Committees

Source: Applied Clinical Trials

ACI Clinical (www.aciclinical.com), a specialty group in clinical research that manages Endpoint Adjudication Committees and Data Monitoring Committees, announced a new, standards-based platform for independent Data Monitoring Committees.

ACI analyzed its DMC member data request trends to create an automated design of standard statistical output, presented in a clinically meaningful format. This understanding of Data Monitoring Committees has allowed ACI to offer new efficiencies while maintaining regulatory-grade quality and features such as double programming. ACI debuted its DMC process was to CDISC members in Europe early this year, in an effort to demonstrate how standardized statistical output may be a highly useful training tool for DMC members.

Industry pricing for DMCs varies based on factors including study size, duration and volume of analysis datasets, tables, figures and listings.

Read the full release here.

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
86%
Borrow lightly from EMA's pathway program?
6%
Create entirely its own pathway program?
7%
View Results
Untitled Document
Source: Applied Clinical Trials,
Click here